Vaccines National Drug Codes Unit Of Sale

$179 / year

The Vaccines National Drug Codes Unit Of Use database facilitate the use of NDC to identify vaccines.
The purpose of the NDC unit of sale dataset is to show the relationships of vaccine secondary packaging NDCs and provide related information for use as reference data for solutions that leverage NDCs.

Complexity

NDCs are assigned by the Federal Drug Administration (FDA) and serve as universal product identifiers for human drugs. These codes indicate the product (FDA Product Code), the manufacturer or packager (FDA Labeler Code), and the packaging (e.g. 5 dose vial).
The format of these codes varies within each component (4-4-2, 5-3-2, or 5-4-1). The combinations of these components have 10 numbers.
In many uses, these 3 components are normalized to a consistent pattern (5-4-2) with dashes between components. A component is left-padded with zero (0) to adjust the size. These more familiar codes are labeled NDC11 in these pages.

In most cases, there are separate NDCs for the Unit of Use (primary) and Unit of Sale (secondary) packaging of a vaccine. That is, the syringe that contains the vaccine has one NDC and the carton of 10 syringes has a different NDC.
Secondary package: The container or packaging that holds the primary packaging. For example, a carton of 5 syringes. This is generally referred to as Unit of Sale or a saleable unit.
Some vaccines (primary package) contain multiple components (e.g. lyophilized agent and diluent agent). The individual components of a multi-component vaccine are each assigned a unique NDC. The NDCs of the individual components differ from the NDC of the secondary packaging.
Each of these component packages (unit of use) will be linked to the unit of sale package.

Date Created

2015-06

Last Modified

2019-09-13

Version

2019-09-13

Update Frequency

Irregular

Temporal Coverage

N/A

Spatial Coverage

United States

Source

John Snow Labs; National Center for Immunization and Respiratory Diseases;

Source License URL

Source License Requirements

N/A

Source Citation

N/A

Keywords

US Vaccine, FDA Vaccine, Vaccine NDC

Other Titles

US Vaccines National Drug Codes Unit Of Sale, Vaccines NDC Codes Unit Of Sale

NameDescriptionTypeConstraints
NDC_Outer_IDID of outer NDCintegerlevel : Nominal required : 1
Outer_LabelerThe Labeler code for the unit of salestringrequired : 1
Outer_ProductThe product code for the unit of salestringrequired : 1
Outer_PackageThe package code for the unit of salestringrequired : 1
Outer_Prop_Namestringrequired : 1
Outer_Generic_NameThe generic name for the unit of sale vaccinestring-
Outer_Labeler_NameThe labeler name for the unit of salestringrequired : 1
Outer_Start_DateMarketing start date of the unit of saledate-
Outer_End_DateEnd marketing date for the unit of saledate-
Outer_Pack_FormThe packaging form of the unit of salestring-
Outer_RouteRoute of administrationstring-
Last_Updated_DateThe date this record was last updateddate-
CVX_CodeCVX for unit of sale NOTE that for some vaccines that have separate vaccine components, the CVX will map to the combined vaccine.integerlevel : Nominal required : 1
CVX_Short_DescriptionShort description of CVXstringrequired : 1
NDCNDC normalized to 11 characters with dashes between components.stringrequired : 1
GTINGTIN (barcode) for Unit of usestring-
NDC Outer IDOuter LabelerOuter ProductOuter PackageOuter Prop NameOuter Generic NameOuter Labeler NameOuter Start DateOuter End DateOuter Pack FormOuter RouteLast Updated DateCVX CodeCVX Short DescriptionNDCGTIN
663492815455ActHIBHAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGENSanofi Pasteur Inc.1993-03-302016-11-28CARTONINTRAMUSCULAR2018-07-1248Hib (PRP-T)49281-0545-05
984492815453ActHIBHAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGENSanofi Pasteur Inc.2016-05-31CARTONINTRAMUSCULAR2018-07-1148Hib (PRP-T)49281-0545-03
6674928140010AdacelHAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGENSanofi Pasteur Inc.2005-06-10CARTONINTRAMUSCULAR2014-03-31115Tdap49281-0400-10
10494928140020AdacelHAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGENSanofi Pasteur Inc.2005-06-10PACKAGEINTRAMUSCULAR2018-07-11115Tdap49281-0400-20
669492814005AdacelHAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGENSanofi Pasteur Inc.2005-06-10CARTONINTRAMUSCULAR2014-01-27115Tdap49281-0400-05
6414928140015AdacelCLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTSanofi Pasteur Inc.2013-10-01PACKAGEINTRAMUSCULAR2014-03-31115Tdap49281-0400-15
6595128513850Adenovirus Type 4 and Type 7 Vaccine, LiveADENOVIRUS TYPE 4 AND TYPE 7 VACCINE, LIVE, ORALTeva Women's Health, Inc.2011-05-31CARTONORAL2018-07-12143Adenovirus types 4 and 751285-0138-50
62233332101AFLURIAINFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)CSL Limited2010-07-302011-06-30CARTONINTRAMUSCULAR2014-01-27140Influenza, seasonal, injectable, preservative free33332-0010-01
70233332141AFLURIAINFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA ACSL Limited2014-07-152015-06-30Carton of 10 syringeINTRAMUSCULAR2014-10-16140Influenza, seasonal, injectable, preservative free33332-0014-01
7033333211410AFLURIAINFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA ACSL Limited2014-07-152015-06-30CARTONINTRAMUSCULAR2018-07-13141Influenza, seasonal, injectable33332-0114-10